| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |